Tapewire

Nasdaq · USD

REGN

REGENERON PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
2010
SEC CIK
0000872589
Parsed reports
687

Last 12 months

Inside the activity.

0 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202601
Feb 2026035
Mar 2026013
Apr 202609
May 2026012
Jun 202600
Jul 202601
Aug 202602
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 09, 2020 Filed Dec 11, 2020 21:07 UTC
MURPHY ANDREW JEVP Research
GrantCommon Stock 1,929 $0.00 $0.00
Disclosure

SEC source: 0001237899-20-000053 · edgardoc.xml · nonDerivative · entry 2

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,350

F2 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:07 UTC
MURPHY ANDREW JEVP Research
GrantCommon Stock 8,285 $0.00 $0.00
Disclosure

SEC source: 0001237899-20-000053 · edgardoc.xml · nonDerivative · entry 1

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,421

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 9, 2025.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:06 UTC
Van Plew Daniel PEVP & General Mgr Industrial O
GrantNon-Qualified Stock Option (right to buy) · Derivative 19,950 $0.00 Strike: $492.00 $0.00
Disclosure

SEC source: 0001708138-20-000115 · edgardoc.xml · derivative · entry 4

Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,950

Underlying: Common Stock · 19,950 shares

Expires 2030-12-09

F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:06 UTC
Van Plew Daniel PEVP & General Mgr Industrial O
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001708138-20-000115 · edgardoc.xml · nonDerivative · entry 2

Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,931

F2 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 9, 2025.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:06 UTC
Van Plew Daniel PEVP & General Mgr Industrial O
GrantCommon Stock 1,930 $0.00 $0.00
Disclosure

SEC source: 0001708138-20-000115 · edgardoc.xml · nonDerivative · entry 1

Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,931

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:06 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 27,680 $0.00 Strike: $492.00 $0.00
Disclosure

SEC source: 0001708138-20-000116 · edgardoc.xml · derivative · entry 6

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,680

Underlying: Common Stock · 27,680 shares

Expires 2030-12-09

F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:06 UTC GrantCommon Stock 2,439 $0.00 $0.00
Disclosure

SEC source: 0001708138-20-000116 · edgardoc.xml · nonDerivative · entry 1

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,088

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:05 UTC
STAHL NEILEVP Research and Development
GrantNon-Qualified Stock Option (right to buy) · Derivative 17,500 $0.00 Strike: $492.00 $0.00
Disclosure

SEC source: 0001237899-20-000052 · edgardoc.xml · derivative · entry 5

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2030-12-09

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:05 UTC
STAHL NEILEVP Research and Development
GrantCommon Stock 1,688 $0.00 $0.00
Disclosure

SEC source: 0001237899-20-000052 · edgardoc.xml · nonDerivative · entry 2

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,715

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:05 UTC
McCourt MarionSVP Commercial
GrantNon-Qualified Stock Option (right to buy) · Derivative 25,000 $0.00 Strike: $492.00 $0.00
Disclosure

SEC source: 0001708138-20-000114 · edgardoc.xml · derivative · entry 4

McCourt Marion · CIK 0001663758 · SVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2030-12-09

F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:05 UTC
McCourt MarionSVP Commercial
GrantCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001708138-20-000114 · edgardoc.xml · nonDerivative · entry 2

McCourt Marion · CIK 0001663758 · SVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,038

F2 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 9, 2025.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:05 UTC
McCourt MarionSVP Commercial
GrantCommon Stock 1,075 $0.00 $0.00
Disclosure

SEC source: 0001708138-20-000114 · edgardoc.xml · nonDerivative · entry 1

McCourt Marion · CIK 0001663758 · SVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,038

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:05 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $492.00 $0.00
Disclosure

SEC source: 0001708138-20-000113 · edgardoc.xml · derivative · entry 9

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2030-12-09

F4 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:05 UTC GrantCommon Stock 1,750 $0.00 $0.00
Disclosure

SEC source: 0001708138-20-000113 · edgardoc.xml · nonDerivative · entry 2

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,102

F2 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 9, 2024.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:05 UTC GrantCommon Stock 969 $0.00 $0.00
Disclosure

SEC source: 0001708138-20-000113 · edgardoc.xml · nonDerivative · entry 1

Fenimore Christopher R. · CIK 0001697422 · VP Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,352

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:04 UTC
Landry Robert EEVP Finance CFO
GrantNon-Qualified Stock Option (right to buy) · Derivative 19,950 $0.00 Strike: $492.00 $0.00
Disclosure

SEC source: 0001237899-20-000051 · edgardoc.xml · derivative · entry 3

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,950

Underlying: Common Stock · 19,950 shares

Expires 2030-12-09

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:04 UTC
Landry Robert EEVP Finance CFO
GrantCommon Stock 1,930 $0.00 $0.00
Disclosure

SEC source: 0001237899-20-000051 · edgardoc.xml · nonDerivative · entry 1

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,903

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:03 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
GrantNon-Qualified Stock Option (right to buy) · Derivative 19,950 $0.00 Strike: $492.00 $0.00
Disclosure

SEC source: 0001237899-20-000050 · edgardoc.xml · derivative · entry 3

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,950

Underlying: Common Stock · 19,950 shares

Expires 2030-12-09

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 21:03 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
GrantCommon Stock 1,930 $0.00 $0.00
Disclosure

SEC source: 0001237899-20-000050 · edgardoc.xml · nonDerivative · entry 1

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,368

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 3 $524.31 $1,572.93
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 10

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,643

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F11 · price: Represents volume-weighted average price of sales of 3 shares of Company stock on December 1, 2020 at prices ranging from $524.00 to $524.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 10 $523.32 $5,233.20
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 9

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,646

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F10 · price: Represents volume-weighted average price of sales of 10 shares of Company stock on December 1, 2020 at prices ranging from $523.03 to $523.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 14 $522.45 $7,314.30
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 8

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,656

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F9 · price: Represents volume-weighted average price of sales of 14 shares of Company stock on December 1, 2020 at prices ranging from $522.00 to $522.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 10 $521.50 $5,215.00
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 7

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,670

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F8 · price: Represents volume-weighted average price of sales of 10 shares of Company stock on December 1, 2020 at prices ranging from $521.04 to $521.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 27 $520.58 $14,055.66
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 6

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,680

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F7 · price: Represents volume-weighted average price of sales of 27 shares of Company stock on December 1, 2020 at prices ranging from $520.14 to $520.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 13 $519.60 $6,754.80
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 5

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,707

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F6 · price: Represents volume-weighted average price of sales of 13 shares of Company stock on December 1, 2020 at prices ranging from $519.30 to $519.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 6 $518.55 $3,111.30
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 4

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,720

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F5 · price: Represents volume-weighted average price of sales of 6 shares of Company stock on December 1, 2020 at prices ranging from $518.10 to $518.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 11 $517.63 $5,693.93
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 3

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,726

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F4 · price: Represents volume-weighted average price of sales of 11 shares of Company stock on December 1, 2020 at prices ranging from $517.03 to $517.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 4 $516.37 $2,065.48
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 2

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,737

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3 · price: Represents volume-weighted average price of sales of 4 shares of Company stock on December 1, 2020 at prices ranging from $516.00 to $516.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 21:09 UTC SaleCommon Stock 2 $515.64 $1,031.28
Disclosure

SEC source: 0001237899-20-000049 · edgardoc.xml · nonDerivative · entry 1

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,741

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · price: Represents volume-weighted average price of sales of 2 shares of Company stock on December 1, 2020 at prices ranging from $515.55 to $515.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.

Read SEC document
November 19, 2020 Filed Dec 11, 2020 21:06 UTC GiftCommon Stock 2,406 $0.00 $0.00
Disclosure

SEC source: 0001708138-20-000116 · edgardoc.xml · nonDerivative · entry 4

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by trust for grandch

Disclosed balance after: 3,609

F2 · ownership.nature: By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.

Read SEC document
November 19, 2020 Filed Dec 11, 2020 21:06 UTC GiftCommon Stock 2,406 $0.00 $0.00
Disclosure

SEC source: 0001708138-20-000116 · edgardoc.xml · nonDerivative · entry 3

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Spouse as Trustee

Disclosed balance after: 47,786

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 114 $556.45 $63,435.30
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 21

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,136

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F17 · price: Represents volume-weighted average price of sales of 114 shares of Company stock on November 17, 2020 at prices ranging from $556.38 to $556.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 64 $553.21 $35,405.44
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 20

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,250

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 73 $552.88 $40,360.24
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 19

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,314

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 141 $551.48 $77,758.68
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 18

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,387

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F16 · price: Represents volume-weighted average price of sales of 141 shares of Company stock on November 17, 2020 at prices ranging from $551.31 to $551.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 206 $550.71 $113,446.26
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 17

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,528

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F15 · price: Represents volume-weighted average price of sales of 206 shares of Company stock on November 17, 2020 at prices ranging from $550.52 to $550.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 283 $549.67 $155,556.61
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 16

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,734

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F14 · price: Represents volume-weighted average price of sales of 283 shares of Company stock on November 17, 2020 at prices ranging from $549.03 to $549.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 216 $548.77 $118,534.32
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 15

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,017

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F13 · price: Represents volume-weighted average price of sales of 216 shares of Company stock on November 17, 2020 at prices ranging from $548.47 to $548.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 148 $547.12 $80,973.76
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 14

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,233

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F12 · price: Represents volume-weighted average price of sales of 148 shares of Company stock on November 17, 2020 at prices ranging from $547.12 to $547.20. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 524 $546.61 $286,423.64
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 13

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,381

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F11 · price: Represents volume-weighted average price of sales of 524 shares of Company stock on November 17, 2020 at prices ranging from $546.08 to $546.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 171 $545.47 $93,275.37
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 12

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,905

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F10 · price: Represents volume-weighted average price of sales of 171 shares of Company stock on November 17, 2020 at prices ranging from $545.37 to $545.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 68 $544.01 $36,992.68
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 11

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,076

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 467 $543.65 $253,884.55
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 10

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,144

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F9 · price: Represents volume-weighted average price of sales of 467 shares of Company stock on November 17, 2020 at prices ranging from $543.07 to $543.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 294 $542.37 $159,456.78
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 9

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,611

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F8 · price: Represents volume-weighted average price of sales of 294 shares of Company stock on November 17, 2020 at prices ranging from $542.15 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 812 $541.42 $439,633.04
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 8

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,905

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F7 · price: Represents volume-weighted average price of sales of 812 shares of Company stock on November 17, 2020 at prices ranging from $541.01 to $541.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 1,442 $540.49 $779,386.58
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 7

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,717

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F6 · price: Represents volume-weighted average price of sales of 1,442 shares of Company stock on November 17, 2020 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 42 $539.87 $22,674.54
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 6

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,159

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F5 · price: Represents volume-weighted average price of sales of 42 shares of Company stock on November 17, 2020 at prices ranging from $539.50 to $539.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 591 $538.37 $318,176.67
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 5

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,201

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F4 · price: Represents volume-weighted average price of sales of 591 shares of Company stock on November 17, 2020 at prices ranging from $538.03 to $538.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 229 $537.38 $123,060.02
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 4

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,792

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3 · price: Represents volume-weighted average price of sales of 229 shares of Company stock on November 17, 2020 at prices ranging from $537.15 to $537.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 21:02 UTC
MURPHY ANDREW JEVP Research
SaleCommon Stock 743 $536.68 $398,753.24
Disclosure

SEC source: 0001708138-20-000108 · edgardoc.xml · nonDerivative · entry 3

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,021

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · price: Represents volume-weighted average price of sales of 743 shares of Company stock on November 17, 2020 at prices ranging from $536.41 to $536.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.